Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page now shows that recruitment has ended and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with related topics, while the Intervention/Treatment label is reformatted and a new Revision: v3.6.0 note is added with the old Revision: v3.5.5 removed.SummaryDifference0.6%

- Check10 days agoChange DetectedA new page revision tag (Revision: v3.5.5) was added and the previous revision tag (v3.5.4) along with links such as Melanoma and related topics/MedlinePlus Genetics were removed; the main study content remains unchanged.SummaryDifference0.2%

- Check17 days agoChange DetectedMelanoma is added as a related topic and a MedlinePlus Genetics reference is linked, expanding cross-references for readers. This enhances navigation and context without altering the trial content.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag has been updated from v3.5.3 to v3.5.4, reflecting a new published revision. Additionally, the related topics block that previously included Melanoma and MedlinePlus Genetics appears to have been removed along with the older revision label.SummaryDifference0.2%

- Check52 days agoChange DetectedUpdates the footer’s Technical “Revision” version indicator from v3.5.2 to v3.5.3 without changing the study details displayed on the page.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.